Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Hepatology Reports

Issue 3/2018

Content (19 Articles)

Invited Commentary

Knowns and Unknowns: the Safety and Efficacy of Cancer Immunotherapy in Chronic Liver Disease

David M. Chascsa, Jorge Rakela

Hepatitis B (JK Lim, Section Editor)

Extrahepatic Manifestations of Chronic Hepatitis B Infection

Victor Virlogeux, Christian Trépo

Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)

Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies

Keaton R. Jones, Craig S. Lammert

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?

Elliot B. Tapper, Roberto Martinez-Macias, Andres Duarte-Rojo

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Treatment of Gastro-Fundal Varices (Including a Discussion of BRTO)

Zachary Henry

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Innovative Care Models in Liver Disease: the Role of Multidisciplinary Teams

Avegail Flores, Chanda K. Ho, Sumeet K. Asrani

Open Access Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

The Role of Anticoagulation in Treating Portal Hypertension

Laura Turco, Filippo Schepis, Erica Villa

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Portal Hypertension Reverses Following Successful Antiviral Treatment for HCV: Fact or Fiction?

Sabela Lens, Claudia Berbel, Xavier Forns, Juan Carlos García-Pagán

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

The Portosystemic Shunt Syndrome and Role of Shunt Embolization in the Management of Hepatic Encephalopathy

Michael D. Leise, Brett E. Fortune

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

DILI Associated with Skin Reactions

Sahand Rahnama-Moghadam, Hans L. Tillmann

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management

Ben L. Da, Gil Ben-Yakov, David Kleiner, Christopher Koh

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-induced Liver Injury Associated with Weight Loss Supplements

James Walter, Victor Navarro, Simona Rossi

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Uncommon Presentations of Idiosyncratic Drug-Induced Liver Injury

Raj Vuppalanchi, Marwan Ghabril

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-Induced Fatty Liver Disease

Niharika Samala, Naga Chalasani

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Beware of HCV and HEV in Patients with Suspected Drug-Induced Liver Injury

Priya Grewal, Jawad Ahmad

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease

Hans L. Tillmann, Huiman X. Barnhart, Jose Serrano, Don C. Rockey

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-Induced Liver Injury in Children

Frank DiPaola, Jean P. Molleston

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Long-Term Outcomes After Drug-Induced Liver Injury

Paul H. Hayashi, Einar S. Bjornsson

Open Access Correction

Correction: Assessment and Management of Sleep Disturbance in Cirrhosis

Chiara Formentin, Maria Garrido, Sara Montagnese

Jun 18
Issue: 2/2018
Dec 18
Issue: 4/2018

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits